The aortic valve is the gate-keeper for blood to circulate from the heart to all parts of the body.
Narrowing of the aortic valve is aortic stenosis. This is a condition that can be congenital or develop over time as a person ages. Most commonly, as people age, this valve is susceptible to calcification leading to its narrowing.
Eventually as time goes by, symptoms of aortic stenosis such as chest discomfort, shortness of breath, exercise intolerance, heart failure, fainting spells, and even death can occur. Read more
In a groundbreaking, multi-centered randomized trial published in The New England Journal of Medicine, researchers, co-led by Mount Sinai’s David H. Adams, MD, determined that a catheter-based heart procedure to replace an aortic valve was superior to surgery for patients who have symptomatic severe aortic stenosis with increased risks. The findings, based on a clinical trial involving 795 patients treated at 45 institutions across the nation, were simultaneously presented by Dr. Adams at the 63rd Annual Scientific Session of the American College of Cardiology on Saturday, March 29, and represent a major advance for heart patients who are at high risk for surgery.